Iron deficiency is common in idiopathic pulmonary arterial hypertension

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1386-1391

  Ruiter, G ^a   Lankhorst, S ^a   Boonstra, A ^a   Postmus, P E ^a   Zweegman, S ^a   Westerhof, N ^a   Van Der Laarse, W J ^a   Vonk Noordegraaf, A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Exercise capacity; Iron deficiency; Pulmonary hypertension

Indexed keywords

FERRITIN; FERROUS FUMARATE;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; IRON DEFICIENCY; IRON STORAGE; IRON TRANSPORT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WALKING;

ADULT; AGED; DIETARY SUPPLEMENTS; EXERCISE TEST; FEMALE; FERRITINS; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; IRON; MALE; MIDDLE AGED;

EID: 79958005700     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00100510     Document Type: Article

References (28)

1. Davies KJ, Maguire JJ, Brooks GA, et al. Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. Am J Physiol 1982; 242: E418-E427. (Pubitemid 12050351)
2. Davies KJ, Donovan CM, Refino CJ, et al. Distinguishing effects of anaemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol 1984; 246: E535-E543. (Pubitemid 14081328)
3. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001; 131: 568S-579S.
4. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001; 131: 676S-688S.
5. Brownlie T, Utermohlen V, Hinton PS, et al. Tissue iron deficiency without anaemia impairs adaptation in endurance capacity after aerobic training in previously untrained females. Am J Clin Nutr 2004; 79: 437-443. (Pubitemid 41115588)
6. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anaemia in patients with chronic heart failure. J Am Coll Cardiol 2006; 48: 1225-1227. (Pubitemid 44345150)
7. Toblli JE, Lombrana A, Duarte P, et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007; 50: 1657-1665. (Pubitemid 47562670)
8. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008; 51: 103-112.
9. Anker S, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.
10. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006; 108: 3204-3209.
11. Handelman GJ, Levin NW. Iron and anaemia in human biology: a review of mechanisms. Heart Fail Rev 2008; 13: 393-404.
12. van der Putten K, Braam B, Jie KE, et al. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol 2008; 4: 47-57. (Pubitemid 350308210)
13. Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anaemia of CKD. Am J Kidney Dis 2010; 55: 726-741.
14. Krasuski R, Hart S, Smith B, et al. Association of anaemia and longterm survival in patients with pulmonary hypertension. Int J Cardiol 2010; (In press).
15. World Health Organization. Technical Report Series No. 405. Nutritional Anaemias: Report of a WHO Scientific Group World Health Organization. Geneva, World Health Organization, 1968. http://whqlibdoc.who.int/trs/WHO-TRS-405.pdf.
16. Opasich C, Cazzola M, Scelsi L, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005; 26: 2232-2237. (Pubitemid 41541385)
17. Nanas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anaemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48: 2485-2489. (Pubitemid 44881220)
18. Silverberg DS, Wexler D, Palazzuoli A, et al. The anaemia of heart failure. Acta Haematol 2009; 122: 109-119.
19. Grzeslo A, Jankowska EA, Witkowski T, et al. Iron deficiency is a common finding in patients with stable chronic heart failure. Eur J Heart Fail Suppl 2006; 5: 132.
20. Murphy CL, Fitzsimons EJ, Jardine AJ, et al. Routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia. Eur J Heart Fail Suppl 2007; 61: 24.
21. Opitz CF, Kirch W, Mueller EA, et al. Bleeding events in pulmonary arterial hypertension. Eur J Clin Invest 2009; 39: Suppl. 2, 68-73.
22. Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: 1628-1631.
23. Dorfmuller P, Perros F, Balabanian K, et al. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003; 22: 358-363. (Pubitemid 36987011)
24. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009; 122: 78-86.
25. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anaemia of inflammation. Blood 2003; 102: 783-788. (Pubitemid 36917762)
26. Selimovic N, Bergh CH, Andersson B, et al. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension. Eur Respir J 2009; 34: 662-668.
27. Smith TG, Balanos GM, Croft QPP, et al. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 2008; 586: 5999-6005.
28. Smith TG, Talbot NP, Privat C, et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 2009; 302: 1444-1450.